Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Editorial: rethinking predictors of response to the low FODMAP diet - should we retire fructose and lactose breath-hydrogen testing and concentrate on visceral hypersensitivity? Authors' reply.
Wilder-Smith CH, Olesen SS, Materna A, Drewes AM. Wilder-Smith CH, et al. Aliment Pharmacol Ther. 2017 May;45(9):1282. doi: 10.1111/apt.14041. Aliment Pharmacol Ther. 2017. PMID: 28370046 Free article. No abstract available.
Reply.
Wilder-Smith CH, Olesen SS, Materna A, Drewes AM. Wilder-Smith CH, et al. Gastroenterology. 2019 Mar;156(4):1221-1222. doi: 10.1053/j.gastro.2019.02.025. Epub 2019 Feb 18. Gastroenterology. 2019. PMID: 30790553 No abstract available.
Breath methane concentrations and markers of obesity in patients with functional gastrointestinal disorders.
Wilder-Smith CH, Olesen SS, Materna A, Drewes AM. Wilder-Smith CH, et al. United European Gastroenterol J. 2018 May;6(4):595-603. doi: 10.1177/2050640617744457. Epub 2017 Nov 15. United European Gastroenterol J. 2018. PMID: 29881615 Free PMC article.
Fermentable Sugar Ingestion, Gas Production, and Gastrointestinal and Central Nervous System Symptoms in Patients With Functional Disorders.
Wilder-Smith CH, Olesen SS, Materna A, Drewes AM. Wilder-Smith CH, et al. Gastroenterology. 2018 Oct;155(4):1034-1044.e6. doi: 10.1053/j.gastro.2018.07.013. Epub 2018 Sep 3. Gastroenterology. 2018. PMID: 30009815
Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study.
Wilder-Smith CH, Röhss K, Bondarov P, Hallerbäck B, Svedberg LE, Ahlbom H. Wilder-Smith CH, et al. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1099-104. doi: 10.1111/j.1365-2036.2004.02272.x. Aliment Pharmacol Ther. 2004. PMID: 15569112 Clinical Trial.
Letter: a physiological dose of lactose and fructose is necessary to demonstrate intolerance--author's response.
Wilder-Smith CH. Wilder-Smith CH. Aliment Pharmacol Ther. 2014 Apr;39(8):901-2. doi: 10.1111/apt.12697. Aliment Pharmacol Ther. 2014. PMID: 24635317 No abstract available.
Commentary: sugar intolerances in functional gastrointestinal disorders - author's reply.
Wilder-Smith CH. Wilder-Smith CH. Aliment Pharmacol Ther. 2013 Jul;38(1):73. doi: 10.1111/apt.12351. Aliment Pharmacol Ther. 2013. PMID: 23738790 No abstract available.
Predictors of response to a low-FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance.
Wilder-Smith CH, Olesen SS, Materna A, Drewes AM. Wilder-Smith CH, et al. Aliment Pharmacol Ther. 2017 Apr;45(8):1094-1106. doi: 10.1111/apt.13978. Epub 2017 Feb 24. Aliment Pharmacol Ther. 2017. PMID: 28233394 Free article.
Repeatability and effect of blinding of fructose breath tests in patients with functional gastrointestinal disorders.
Wilder-Smith CH, Olesen SS, Materna A, Drewes AM. Wilder-Smith CH, et al. Neurogastroenterol Motil. 2019 Feb;31(2):e13497. doi: 10.1111/nmo.13497. Epub 2018 Nov 4. Neurogastroenterol Motil. 2019. PMID: 30393978 Clinical Trial.
Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders.
Wilder-Smith CH, Materna A, Wermelinger C, Schuler J. Wilder-Smith CH, et al. Aliment Pharmacol Ther. 2013 Jun;37(11):1074-83. doi: 10.1111/apt.12306. Epub 2013 Apr 9. Aliment Pharmacol Ther. 2013. PMID: 23574302 Free PMC article.
80 results
Jump to page
Feedback